PQA

OCTOBER 24, 2022

PQA’s talented staff is dedicated to improving medication safety, adherence and appropriate use. I received my Bachelor of Science in Health Policy and Management from the Gillings School of Global Public Health at the University of North Carolina, Chapel Hill. This blog is one in a series profiling PQA's staff.

Hospitals 52

Hospitals 52

Pharmaceutical Technology

FEBRUARY 24, 2023

The overhaul will address drug marketing exclusivity length, pricing, patient access, innovation incentives, antimicrobial resistance, clinical trials, supply chain security and shortages, and environmental impact. But others do not accept that the EU is less competitive for the pharma industry than North America and Asia.

Documentation 64

Documentation 64

pharmaphorum

OCTOBER 26, 2022

Chiesi has proven its dedication to global public health through its designation as a certified Benefit Corporation (B Corp) since 2019. When thinking about their work in rare disease, Chiesi points to the United Nations charter and its call for “health for all at all ages.”. Caring for a global community. is approximately $2.2

Patient Care 96

Patient Care FDA 96

pharmaphorum

JUNE 8, 2021

But we are glad to see the situation for innovative drugs in Asian markets improving, especially in mainland China and South Korea, where policies, societies and regulations are actively promoting innovation. “At At the same time, lots of people with experience at multinational pharmaceutical companies have chosen to return home.

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

ISPE

NOVEMBER 3, 2022

Potential areas for global convergence could include preclinical study requirements; environmental assessments; manufacturing information such as identity, purity, and potency; and clinical outcomes. Health Canada. Health Canada has been working as part of a consortium since 2018, Hamel said. General Manager of Medicines.

Communication 98

Communication FDA Documentation Vaccines 98

ISPE

JULY 19, 2023

™ opens new opportunities for quality, safety, productivity, and patient benefit. Uncertainty: Is linked to unpredictable demands, inventory, and capacity needs; new competitors entering the market; new government policies, etc. ™ and Environmental Safety Governance Joydeep Ganguly, SVP Corporate Operations, Gilead Sciences Inc.,

Documentation 98

Documentation FDA Labelling Communication 98

pharmaphorum

MAY 26, 2022

Within pharma and healthcare, where greater representation has been proven to lead to better health outcomes for all patients and the pharmaceutical companies developing medicines, change is also happening. Vaccines approved for public use require comprehensive RCTs to establish their safety and efficacy.

Packaging 143

Packaging Vaccines Generic Medicine Compounding 143

OctariusRx

MARCH 27, 2023

This week we discuss the implications of the new guidelines on injection practices and medication safety. We all know that having comprehensive infection prevention and control practices is a key component of patient safety and high-quality care. What steps must you take to update your practices?

Clinic Management 66

Clinic Management 66

Pharmaceutical Technology

DECEMBER 20, 2022

Maintaining sterility is critical in the final steps of parenteral drug processing, ensuring doses are free from microbial contamination that could affect patient safety. By clicking the Download Free Whitepaper button, you accept the terms and conditions and acknowledge that your data will be used as described in the Cytiva Privacy Policy.

Communication 52

Communication FDA 52

European Pharmaceutical Review

JULY 1, 2022

This evolving focus is clearly visible in the growing emphasis now placed by many global businesses on environmental, social and governance (ESG) issues – and especially the ‘social’ element. Strong ESG policies also attract investments. Measuring the S in ESG.

Pharmaceutical Companies 85

Pharmaceutical Companies Pharmaceutical Companies Documentation 85

ISPE

SEPTEMBER 12, 2022

Regulatory Operations and Enforcement Branch (ROEB), Health Canada. Senior Policy Advisor for the Global Compliance Branch 3. Consumer Safety Officer. Regulatory Operations and Enforcement Branch (ROEB), Health Canada. Consumer Safety Officer. Regulatory Operations and Enforcement Branch (ROEB), Health Canada.

FDA 52

FDA Documentation Communication 52

The Thyroid Pharmacist

DECEMBER 7, 2022

Flame retardants began to be manufactured in consumer products in the 1960s, to address fire safety regulations. Researchers are concerned they could have even worse health effects than the PBDEs they were meant to safely replace. [10]. Risks to Fetal Development and Maternal Health.

Health and Personal Care Stores 55

Health and Personal Care Stores Labelling Immunization Compounding 55

ISPE

JULY 5, 2023

Two of the most significant policy developments since 2014 have been the release of the Quality Considerations for Continuous Manufacturing draft guidance in 2019 and the International Council for Harmonisation (ICH) Q13 guidance on CM of drug substances and drug products in 2023. product quality attributes).

FDA 52

FDA Dosage Documentation Pharmaceutical Companies 52

ISPE

SEPTEMBER 11, 2023

These technologies also offer a combination of closed, connected process and the centralized control facilitates improved efficiency, safety, and compliance. It also reduces environmental impact because it requires fewer chemicals and less high-purity water and heat. 2 October 2019. iSpeak blog. link] 33 Adiga, R., 3 (2020):e2970.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

PharmaShots

FEBRUARY 27, 2023

The theme of the event was Innovation, Advanced Technology, Current Challenges & Opportunities in Pharma & Healthcare Industry under which a series of presentation sessions and panel discussions were held related to pharma trends, APIs, policy reforms, AI, metaverse, current regulatory trends and the direction of pharma and drug discovery.

Packaging 40

Packaging Hospitals FDA Pharmaceutical Companies 40

ISPE

MARCH 7, 2023

Governments have entered into international commitments to reduce climate impact (carbon emissions) and protect nature (water, land, air, and biodiversity) with policy frameworks established to facilitate and drive progress against agreed targets. These expectations are defined in various national codes. 3 Science Based Targets Initiative.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

MARCH 15, 2023

Environmental Sustainability in Biopharmaceutical Facility Design Trudy Patterson Wed, 03/15/2023 - 09:13 Online Exclusives March / April 2023 Environmental Sustainability in Biopharmaceutical Facility Design William G. Table 1: Facility environmental sustainability tools and example values. 7 An integrative (vs.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

ISPE

MARCH 6, 2023

While there may be economic benefits, these are rapidly being eroded with fossil fuel price increases and ratcheting local and national government policy leading to increased carbon taxation. The technology is proven to deliver the required quality and reliability at a lower environmental and cost impact. 10 a b Carlson, C.,

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Compounding 52

ISPE

MAY 9, 2023

North Carolina Central University (Durham) has the Biomanufacturing Research Institute and Technology Enterprise, which funds health-related research and workforce training. Campbell University College of Pharmacy & Health Sciences was the first university in the Triangle to offer an educational program in the pharmaceutical sciences.

Vaccines 94

Vaccines Pharmaceutical Companies Pharmaceutical Companies Medical Schools 94

ISPE

AUGUST 29, 2022

Health authorities have specific regulations and guidelines that govern reporting requirements necessary to implement postapproval variations; however, regulatory submissions for a given change can vary based on differing regional requirements as specified by the health authority conducting the review.

Documentation 52

Documentation FDA Communication Packaging 52

ISPE

SEPTEMBER 8, 2023

Internationally, acceptable scientific guidelines—primarily applicable to commercial registration of new and generic drug products and drug substances—have dramatically improved regulatory alignment for many technical approaches focused on safety, efficacy, and quality of drug products. 22 June 2023. EMA/321483/2020. 3 July 2020.

FDA 52

FDA Dosage Documentation Communication 52